Programme Supplement [International Conference on AIDS (16th: 2006: Toronto, Canada)]

Roadmap
Microbicid

12:45
Monday 14 August Session TUSSO

Global Leaders Speak Out

10:15
Poster Exhibition
MOPE0792
Poster Exhibition
MOPE0797
16:15
Session MOSY08

Roadmaps

Programme
Contributors
Index

Tuesday 15 Augu
08:45
Session TUPLO2
10:15
Poster Exhibition
TUPE0423
Poster Exhibition
TUPE0439
Poster Exhibition
TUPE0429
Poster Exhibition
TUPE0893
Poster Exhibition
TUPE0438
Poster Exhibition
TUPE0959
Poster Exhibition
TUPE0154
Poster Exhibition
TUPE0922

Addressing HIV Prevention Trial
Challenges through Sociobehavioral
Research: Cameroon's Tenofovir Trial
Participant Experiences of the Tenofovir
HIV Prevention Trial in Nigeria and
Cameroon: Implications for Recruitment
and Retention
Novel Targets for Drug Development:
Cell-virus interactions as targets for drugs
development, the example o the VifAPOBEC3G
HIV Assembly in the endocytic pathway:
Opportunities for the identification
of novel anti-HIV drug targets. Entry
inhibition as models for microicide
development
st
Proven Approaches and New Technologies
Factors influencing adherence to Pills for
Pre-exposure Prophylaxis: Lessons learnt
from phase 2 trial in Nigeria
Modeling Phase III Microbicide Clinical
Trial Costs
Ethical Challenges for HIV Prevention
Trials in Africa: The cultural meaning of
pill-taking and local research literacy in
Tema, Ghana
Building Public Support for Microbicides in
Europe and North America
An Analytical Overview of the Microbicide
Pipeline
The Development of the Canadian
Microbicides Action Plan as a Model of
Multi-Sectoral Collaboration
Determining the feasibility of utilizing the
microbicide applicator compliance assay
for use in clinical trials
Rectal microbicides in demand: engaging
men and women in rectal microbicides
advocacy

18:30
Global Village

SNew Prevention Technologies

Wednesday 16 August

10:15
Poster Exhibition A Framework for Future Microbicide
WEPE0896 Access in Developing Countries
Poster Exhibition
WEPE0770 Perceptions of Sexual Partnerships, HIV
Risk, and HIV Infection in Ghana, Nigeria,
Cameroon, and Malawi: Multiple partners,
marriage, and (in)fidelity
12:45
Session WEKC104 Adding it all up: Funding for HIV
Vaccine and Microbicide Research and
Development Between 2000 and 2005
16:15
Session WEAX0404 The Role of Alcohol Consumption in
Transactional Sex in Malawi: A Factor in
HIV Prevention Intervention Design

Session TUKC1
Session TUSY02
Session TUSY07
16:15
Session TUAEO301

Accelerating Prevention Research to End
the Epidemic
Prevention: HIV Prevention: Evolution and
Change in Programme Development
Women, Taking Charge of the Response
The UNAIDS Global Coalition on Women
and AIDS Session
1 Ethical Issues in Clincial Trials: Tenofovir
and Beyond Global Campaign for
Microbicides Oral Presentation: Making
the Ethical Feasible: Assuring Future
Access to Care to Those Who SeroConvert in Microbicide Trials Making the
ethical feasible: assuring future access
to care to those who sero-convert in
Smicrobicide trialsRevisiting the ethics of HIV
prevention research in developing countries
Overcoming the challenges of prevention
research: lessons learned from the tenofovir
pre-exposure prophylaxis trialsBeyond
the checklist: assessing understanding of
participation in HIV vaccine trials in South
AfricaInfluencing legislative processes and
policy development in order to improve
research ethics

Session WEAA05 Microbicide Development

20:00
Networking Event

Microbicide Networking Reception

Thursday 17 August
10:15
Poster Exhibition Findings from a double-blind, randomized,
placebo-controlled trial of tenofovir
disoproxil fumarate (TDF) for prevention
of HIV infection in women

XVI INTERNATIONAL AIDS CONFERENCE * 13-18 AUGUST 2006 * TORONTO CANADA * PROGRAMME SUPPLEMENT